| 000 | 01357 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513122956.0 | ||
| 264 | 0 | _c19970825 | |
| 008 | 199708s 0 0 eng d | ||
| 022 | _a0022-1899 | ||
| 024 | 7 |
_a10.1086/514050 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSpiller, O B | |
| 245 | 0 | 0 |
_aNeutralization of cytomegalovirus virions: the role of complement. _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _cAug 1997 |
||
| 300 |
_a339-47 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAntibodies, Viral |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aComplement Activation _ximmunology |
| 650 | 0 | 4 |
_aComplement C3 _xmetabolism |
| 650 | 0 | 4 |
_aComplement C9 _ximmunology |
| 650 | 0 | 4 | _aComplement Hemolytic Activity Assay |
| 650 | 0 | 4 |
_aComplement Inactivator Proteins _xanalysis |
| 650 | 0 | 4 |
_aComplement System Proteins _ximmunology |
| 650 | 0 | 4 |
_aCytomegalovirus _ximmunology |
| 650 | 0 | 4 | _aFibroblasts |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeutralization Tests _xmethods |
| 650 | 0 | 4 |
_aVirion _ximmunology |
| 700 | 1 | _aHanna, S M | |
| 700 | 1 | _aDevine, D V | |
| 700 | 1 | _aTufaro, F | |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 176 _gno. 2 _gp. 339-47 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1086/514050 _zAvailable from publisher's website |
| 999 |
_c9217765 _d9217765 |
||